Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Marieka Gryzenhout receives NRF-NSTF Award
2013-07-03

 

Dr Gryzenhout
Photo: Sonia Small
03 July 2013

“The award serves to prove that my type of research is truly relevant.” These are the words of Dr Marieka Gryzenhout of the Department of Plant Sciences at the UFS, who received the T W Kambule NRF-NSTF Award as emerging researcher in June 2013.

The award from the National Research Foundation (NRF) and the National Science and Technology Forum (NSTF) gives recognition to her outstanding contribution to science, engineering, technology and innovation (SETI) in the country.

Dr Gryzenhout is also part of the Vice-Chancellor’s Prestige Scholar Programme.

“It was an honour to be chosen as a finalist, but to even win it? Die award indicates the importance of fungi and plant pathogens, and their presence in various biological systems and that it is important to identify and categorise significant plant pathogens and fungi to enable easier access for users of these names.”

Dr Gryzenhout was in the US on the evening of the awards ceremony, attending a workshop on the identification and research of another fungus group, Fusarium. “This group is extremely important, since it includes important plant pathogens, producers of toxins in food and feed, as well as animal and human pathogens, and it also plays important ecological roles.”

She attended the Kansas State University in Kansas and paid a visit to the Bacterial Foodborne Pathogens and Mycology Unit of the US Department of Agriculture in Illinois.

Dr Gryzenhout is also a finalist in the Women in Science Awards hosted by the Department of Science and Technology. The winner will be announced in August 2013. Prof Maryke Labuschagne and Rose Lekhooa are also nominees.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept